updates in treatment options for patients with aml
Published 2 years ago • 1.1K plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
2:25
updates on chemotherapy-free treatment approaches for apl
-
1:11
the treatment of aml within the united kingdom nhs framework
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:54
new developments in aml treatment
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
5:34
updates on maintenance therapies in aml
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
3:09
overcoming challenges with targeted therapies for cll: high-risk mutations and btki resistance
-
1:19
new treatments for aml
-
2:09
advances in the management of fit adults with aml
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
5:11
the frontline treatment strategy for newly diagnosed aml
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
2:15
extending remission in patients with aml who become eligible for allosct following targeted therapy
-
1:46
personalized treatments to manage post-transplantation outcomes in aml: insights from morpho
-
1:33
the use of gilteritinib in post-transplant maintenance for aml with flt3-itd
-
1:19
astx727 a molecularly-targeted agent as personalized maintenance therapy in patients with aml
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
2:45
continuity of care for patients with hematological predispositions to aml